Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alphatec Holdings, Inc.ATEC · Entity 4720 | Director | June 10, 2026 | June 12, 2026 |
| Orthofix Medical Inc.OFIX · Entity 1975 | Director · President & CEO | February 28, 2023 | March 02, 2023 |
| REGENTIS BIOMATERIALS LTD.RGNT · Entity 7824 | Director | July 09, 2026 | July 13, 2026 |
| SI-BONE, Inc.SIBN · Entity 2501 | Director | June 09, 2023 | June 13, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alphatec Holdings, Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 264,283 |
Reported balance
After 2026-06-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-10 · Grant · Acquired 32,012 · Balance 264,283 F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 10, 2026, issuer granted to the reporting person 32,012 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of issuer's common stock. The restricted stock units vest on the earlier of (a) the next annual meeting of stockholders and (b) the death or resignation of the reporting person. In the event of death or resignation of the reporting person, the grant will vest pro-rata based on the number of actual days served by the reporting person from the time of the grant to such death or resignation, divided by 365.
Orthofix Medical Inc.
Report date February 28, 2023 · Filed March 02, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 377,741 |
Reported balance
After 2023-02-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-02-28 · Tax withholding · Disposed 16,290 · Balance 377,741 F1: Includes 217,134 unvested restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 217,134 unvested restricted stock units.
REGENTIS BIOMATERIALS LTD.
Report date July 09, 2026 · Filed July 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.16 · Expires 2036-05-28 | Direct | 24,826 |
Reported balance
After 2026-07-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-09 · Grant · Acquired 24,826 · Balance 24,826 F1: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026. F2: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: This option grant was approved by the Board of Directors of the Issuer on May 28, 2026, subject to shareholder approval, which was obtained on July 9, 2026.
F2: This options grant shall vest on a quarterly basis, with one-twelfth (1/12) vesting on August 28, 2026, and an additional one-twelfth vesting on last day of each subsequent three-month period thereafter, subject to the Reporting Person's continuous employment through the applicable vesting date, until the options fully vest on the third anniversary of the grant date, or May 28, 2029.
SI-BONE, Inc.
Report date June 09, 2023 · Filed June 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 57,209 |
Reported balance
After 2023-06-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-06-09 · Grant · Acquired 4,866 · Balance 57,209 F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will vest 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date.
F2: Includes 4,866 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SeaSpine Holdings Corp
Report date January 05, 2023 · Filed January 10, 2023
Section 16 reporting ended · disclosed 2023-01-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 1
1 source rowRow 1 · 2023-01-05 · Disposition to issuer · Disposed 333,797 · Balance 0 F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-01-05 · Disposition to issuer · Disposed 52,392 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units. F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-01-05 · Disposition to issuer · Disposed 236,779 · Balance 0 F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units. F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.68 · Expires 2023-08-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-01-05 · Disposition to issuer · Disposed 325,000 · Balance 0 F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share. F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.19 · Expires 2024-01-27 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2023-01-05 · Disposition to issuer · Disposed 149,074 · Balance 0 F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share. F9: The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.24 · Expires 2027-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2023-01-05 · Disposition to issuer · Disposed 77,881 · Balance 0 F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share. F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.01 · Expires 2028-01-01 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-01-05 · Disposition to issuer · Disposed 121,830 · Balance 0 F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share. F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.93 · Expires 2028-04-23 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-01-05 · Disposition to issuer · Disposed 8,871 · Balance 0 F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share. F15: The option fully vested and became exercisable on June 21, 2020. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.86 · Expires 2029-01-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-01-05 · Disposition to issuer · Disposed 261,699 · Balance 0 F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share. F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $15.00 · Expires 2030-02-28 | Direct | 0 |
Reported balance
After 2023-01-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-01-05 · Disposition to issuer · Disposed 31,866 · Balance 0 F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share. F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, SeaSpine Holdings Corporation, which became effective on January 5, 2023, in exchange for 138,959 Orthofix Medical Inc. ("Orthofix") ordinary shares having a market value of $22.76 per share at the effective time of the merger.
F2: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock.
F3: The restricted stock units vest in three equal installments on each of January 28, 2022, 2023 and 2024.
F4: These restricted stock units were assumed by Orthofix in the merger and replaced by 21,810 Orthofix restricted stock units.
F5: The restricted stock units vest in three equal installments on each of February 28, 2023, 2024 and 2025.
F6: These restricted stock units were assumed by Orthofix in the merger and replaced by 98,571 Orthofix restricted stock units.
F7: The option vests as to 25% of the underlying shares on May 1, 2016 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F8: This option was assumed by Orthofix in the merger and replaced with an option to purchase 135,297 shares of Orthofix at a price of $37.67 per share.
F9: The option vests as to 6.25% on June 1, 2016, 6.25% on June 30, 2016 and the remaining 87.5% in fourteen equal quarterly installments thereafter.
F10: This option was assumed by Orthofix in the merger and replaced with an option to purchase 62,059 shares of Orthofix at a price of $34.09 per share.
F11: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F12: This option was assumed by Orthofix in the merger and replaced with an option to purchase 32,421 shares of Orthofix at a price of $43.82 per share.
F13: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F14: This option was assumed by Orthofix in the merger and replaced with an option to purchase 50,717 shares of Orthofix at a price of $28.85 per share.
F15: The option fully vested and became exercisable on June 21, 2020.
F16: This option was assumed by Orthofix in the merger and replaced with an option to purchase 3,692 shares of Orthofix at a price of $23.86 per share.
F17: The option vests as to 25% of the underlying shares on January 28, 2022 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F18: This option was assumed by Orthofix in the merger and replaced with an option to purchase 108,945 shares of Orthofix at a price of $40.50 per share.
F19: The option vests as to 25% of the underlying shares on February 28, 2023 and the remaining 75% in twelve substantially equal quarterly installments thereafter.
F20: This option was assumed by Orthofix in the merger and replaced with an option to purchase 13,265 shares of Orthofix at a price of $36.04 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 01, 2021 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 27,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,293 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 21:13 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,058 | $8.92 | $9,437.36 |
DisclosureSEC source: 0001637761-21-000015 · wf-form4_160988120481159.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,865 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2020. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 20:09 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,202 | $8.90 | $10,697.80 |
DisclosureSEC source: 0001637761-20-000090 · wf-form4_159372051058278.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,807 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 30, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 22:24 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantCommon Stock | 8,797 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-20-004587 · primarydocument.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,171 F1 · shares: Reflects shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The shares subject to the restricted stock unit will be vesting 100% upon the earlier of (i) the next annual general meeting of the stockholders of the Company or (ii) the date one year from the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Company's Board of Directors until such date. F2 · balance_after: Includes 8,797 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| April 23, 2020 Filed Apr 24, 2020 20:22 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,871 | $0.00 Strike: $9.93 | $0.00 |
DisclosureSEC source: 0001637761-20-000039 · wf-form4_158775971615468.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,871 Underlying: Common Stock · 8,871 shares Expires 2028-04-23 F1 · derivative.exercise_date: The option will fully vest and become exercisable on June 21, 2020, subject to the Reporting Person's continued service to the issuer. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 121,830 | $0.00 Strike: $12.01 | $0.00 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · derivative · entry 10 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,830 Underlying: Common Stock · 121,830 shares Expires 2028-01-01 F9 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2021 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 36,549 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · derivative · entry 9 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,549 Underlying: Common Stock · 36,549 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F8 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. F8 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2021, 2022 and 2023. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 7,788 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · derivative · entry 8 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,577 Underlying: Common Stock · 7,788 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. F7 · derivative.expiration_date: The reporting person was granted 23,365 restricted stock units on January 1, 2019, which vest in three equal installments on each of January 1, 2020, 2021, and 2022. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 27,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · derivative · entry 7 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,428 Underlying: Common Stock · 27,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. F6 · derivative.expiration_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 35,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · derivative · entry 6 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,939 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F5 · derivative.expiration_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 38,128 | $12.01 | $457,917.28 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · nonDerivative · entry 5 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,605 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2020. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 7,788 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · nonDerivative · entry 4 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 316,733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 27,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · nonDerivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2020 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 35,939 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 281,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2019 Filed Jan 3, 2020 02:17 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 593 | $10.21 | $6,054.53 |
DisclosureSEC source: 0001637761-20-000010 · wf-form4_157801782812899.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,578 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on December 31, 2019. Read SEC document |
| December 13, 2019 Filed Dec 13, 2019 20:51 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | PurchaseCommon Stock | 20,000 | $11.12 | $222,400.00 |
DisclosureSEC source: 0001637761-19-000108 · wf-form4_157627024808661.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,985 F1 · price: The price reported is a weighted average. These shares were purchased in multiple transactions at prices ranging from not less than $10.99 to not more than $11.28. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. Read SEC document |
| June 28, 2019 Filed Jul 2, 2019 20:34 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 994 | $11.26 | $11,194.93 |
DisclosureSEC source: 0001637761-19-000087 · wf-form4_156209962948008.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,985 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019. F3 · balance_after: On the Form 4 filed by the reporting person on January 3, 2019, the amount of shares acquired by the reporting person in the transaction reported in that Form 4 related to the acquisition of shares under the ESPP, and the amount of securities beneficially owned by the reporting person following such acquisition, were both overstated by 40. The amount reported in this Column 5 reflects a reduction of 40 shares to correct this error. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:37 UTC | SI-BONE, Inc. SIBN · Entity 2501 | GrantStock Options (Right to buy) · Derivative | 15,741 | $0.00 Strike: $17.72 | $0.00 |
DisclosureSEC source: 0001562180-19-003569 · primarydocument.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,741 Underlying: Common Stock · 15,741 shares Expires 2029-06-12 F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantEmployee Stock Option (Right to Buy) · Derivative | 77,881 | $0.00 Strike: $18.24 | $0.00 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · derivative · entry 8 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,881 Underlying: Common Stock · 77,881 shares Expires 2027-01-01 F8 · derivative.exercise_date: The option vests as to 25% of the underlying shares on January 1, 2020 and the remaining 75% in twelve substantially equal quarterly installments thereafter. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 23,365 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · derivative · entry 7 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,365 Underlying: Common Stock · 23,365 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F7 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2020, 2021 and 2022. F7 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2020, 2021 and 2022. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 27,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · derivative · entry 6 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,856 Underlying: Common Stock · 27,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F6 · derivative.exercise_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. F6 · derivative.expiration_date: The reporting person was granted 82,284 restricted stock units on March 5, 2018, which vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 35,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · derivative · entry 5 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,939 Underlying: Common Stock · 35,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F5 · derivative.exercise_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F5 · derivative.expiration_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Tax withholdingCommon Stock | 23,611 | $18.24 | $430,664.64 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · nonDerivative · entry 4 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,031 F4 · shares: These shares were withheld by the issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units that occurred on January 1, 2019. No shares were sold in connection with this transaction. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 27,428 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · nonDerivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,642 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| January 01, 2019 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 35,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2018 Filed Jan 3, 2019 21:54 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,206 | $6.43 | $7,749.76 |
DisclosureSEC source: 0001637761-19-000007 · wf-form4_154655247165559.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,276 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (ESPP) in transactions that were exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 21:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionSeries 7 Preferred Stock · Derivative | 9,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055708 · doc4.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,966 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · price: The Issuer's Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.exercise_date: The Issuer's Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. F1 · derivative.expiration_date: The Issuer's Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| October 19, 2018 Filed Oct 19, 2018 21:01 UTC | SI-BONE, Inc. SIBN · Entity 2501 | ConversionCommon Stock | 9,966 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055708 · doc4.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Issuer's Series 7 Preferred Stock automatically converted into an equal number of shares of Issuer's common stock immediately upon the closing of the Issuer's initial public offering and has no expiration date. Read SEC document |
| June 29, 2018 Filed Jun 29, 2018 22:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 2,101 | $6.43 | $13,501.03 |
DisclosureSEC source: 0001637761-18-000110 · wf-form4_153031060130502.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,070 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 19:37 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 82,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000054 · wf-form4_152045145227574.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,284 Underlying: Common Stock · 82,284 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F2 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. F2 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2019, 2020 and 2021. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 01:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 35,938 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-18-000014 · wf-form4_151502821771920.xml · derivative · entry 3 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,877 Underlying: Common Stock · 35,938 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. F4 · derivative.exercise_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. F4 · derivative.expiration_date: The reporting person was granted 107,815 restricted stock units on February 2, 2017, which vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 01:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 35,938 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-18-000014 · wf-form4_151502821771920.xml · nonDerivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Read SEC document |
| December 31, 2017 Filed Jan 4, 2018 01:10 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | OtherCommon Stock | 1,266 | $6.43 | $8,135.32 |
DisclosureSEC source: 0001637761-18-000014 · wf-form4_151502821771920.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,031 F1 · kind: These shares were acquired under the issuer's 2015 Employee Stock Purchase Plan (the "ESPP") in a transaction that was exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 19:35 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 2,040 | $6.43 | $13,109.04 |
DisclosureSEC source: 0001637761-17-000141 · wf-form4_149928331011010.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,765 F1 · kind: These shares were acquired under the Company's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). F2 · price: In accordance with the Company's 2015 Employee Stock Purchase Plan, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2017, which was the first trading day of the applicable offering period. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 16:04 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionRestricted Stock Units · Derivative | 40,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000053 · wf-form4_148950746878177.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F2 · derivative.exercise_date: The reporting person was granted 40,038 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. F2 · derivative.expiration_date: The reporting person was granted 40,038 restricted stock units on February 2, 2017, which vested in full on March 10, 2017. Read SEC document |
| March 10, 2017 Filed Mar 14, 2017 16:04 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | Exercise / conversionCommon Stock | 40,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001637761-17-000053 · wf-form4_148950746878177.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 22:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 107,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000025 · wf-form4_148641938216128.xml · derivative · entry 2 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,815 Underlying: Common Stock · 107,815 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. F3 · derivative.expiration_date: The restricted stock units vest in three equal installments on each of January 1, 2018, 2019 and 2020. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 22:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantRestricted Stock Units · Derivative | 40,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001637761-17-000025 · wf-form4_148641938216128.xml · derivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,038 Underlying: Common Stock · 40,038 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of SeaSpine Holdings Corporation common stock. F2 · derivative.exercise_date: The restricted stock units vest in full on March 10, 2017. F2 · derivative.expiration_date: The restricted stock units vest in full on March 10, 2017. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 16:16 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | GrantCommon Stock | 270 | $6.72 | $1,813.05 |
DisclosureSEC source: 0001637761-17-000006 · wf-form4_148354655779197.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,687 F1 · kind: These shares were acquired under the Company's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| November 18, 2016 Filed Nov 21, 2016 23:26 UTC | SeaSpine Holdings Corp SPNE · Entity 120832 | PurchaseCommon Stock | 25,000 | $7.00 | $175,000.00 |
DisclosureSEC source: 0001637761-16-000139 · wf-form4_147977076424679.xml · nonDerivative · entry 1 Valentine Keith · CIK 0001289408 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,417 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.93 to $7.23, inclusive. The reporting person undertakes to provide to SeaSpine, any security holder of SeaSpine, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.